TY - JOUR
T1 - Cholangiocyte pathobiology
AU - Banales, Jesus M.
AU - Huebert, Robert C.
AU - Karlsen, Tom
AU - Strazzabosco, Mario
AU - LaRusso, Nicholas F.
AU - Gores, Gregory J.
N1 - Funding Information:
J.M.B. has received grant support from the Spanish Ministries of Economy and Competitiveness (FIS PI15/01132, FIS PI18/01075 and Miguel Servet Programme CON14/ 00129) co-financed by ‘Fondo Europeo de Desarrollo Regional’ (FEDER); ISCIII (CIBERehd), Spain; BIOEF (Basque Foundation for Innovation and Health Research); EiTB Maratoia BIO15/CA/016/BD; the Department of Health of the Basque Country (2017111010); and the Scientific Foundation of the Spanish Association Against Cancer (AECC). The authors also acknowledge the US National Institutes of Health grants DK63947 (G.J.G.); DK057993, DK084567 and DK24031 (N.F.L.); and DK100575 and DK113339 (R.C.H.). G.J.G., N.F.L. and R.C.H. further acknowledge support from the Carlos Family Foundation and the Mayo Clinic. M.S. has recieved support from the US National Institutes of Health Grants DK079005, DK096096 and DK34989, the Silvio O. Conte Digestive Diseases Research Core Centers and PSC Partners Seeking a Cure.
Publisher Copyright:
© 2019, Springer Nature Limited.
PY - 2019/5/1
Y1 - 2019/5/1
N2 - Cholangiocytes, the epithelial cells lining the intrahepatic and extrahepatic bile ducts, are highly specialized cells residing in a complex anatomic niche where they participate in bile production and homeostasis. Cholangiocytes are damaged in a variety of human diseases termed cholangiopathies, often causing advanced liver failure. The regulation of cholangiocyte transport properties is increasingly understood, as is their anatomical and functional heterogeneity along the biliary tract. Furthermore, cholangiocytes are pivotal in liver regeneration, especially when hepatocyte regeneration is compromised. The role of cholangiocytes in innate and adaptive immune responses, a critical subject relevant to immune-mediated cholangiopathies, is also emerging. Finally, reactive ductular cells are present in many cholestatic and other liver diseases. In chronic disease states, this repair response contributes to liver inflammation, fibrosis and carcinogenesis and is a subject of intense investigation. This Review highlights advances in cholangiocyte research, especially their role in development and liver regeneration, their functional and biochemical heterogeneity, their activation and involvement in inflammation and fibrosis and their engagement with the immune system. We aim to focus further attention on cholangiocyte pathobiology and the search for new disease-modifying therapies targeting the cholangiopathies.
AB - Cholangiocytes, the epithelial cells lining the intrahepatic and extrahepatic bile ducts, are highly specialized cells residing in a complex anatomic niche where they participate in bile production and homeostasis. Cholangiocytes are damaged in a variety of human diseases termed cholangiopathies, often causing advanced liver failure. The regulation of cholangiocyte transport properties is increasingly understood, as is their anatomical and functional heterogeneity along the biliary tract. Furthermore, cholangiocytes are pivotal in liver regeneration, especially when hepatocyte regeneration is compromised. The role of cholangiocytes in innate and adaptive immune responses, a critical subject relevant to immune-mediated cholangiopathies, is also emerging. Finally, reactive ductular cells are present in many cholestatic and other liver diseases. In chronic disease states, this repair response contributes to liver inflammation, fibrosis and carcinogenesis and is a subject of intense investigation. This Review highlights advances in cholangiocyte research, especially their role in development and liver regeneration, their functional and biochemical heterogeneity, their activation and involvement in inflammation and fibrosis and their engagement with the immune system. We aim to focus further attention on cholangiocyte pathobiology and the search for new disease-modifying therapies targeting the cholangiopathies.
UR - http://www.scopus.com/inward/record.url?scp=85062770224&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062770224&partnerID=8YFLogxK
U2 - 10.1038/s41575-019-0125-y
DO - 10.1038/s41575-019-0125-y
M3 - Review article
C2 - 30850822
AN - SCOPUS:85062770224
SN - 1759-5045
VL - 16
SP - 269
EP - 281
JO - Nature Reviews Gastroenterology and Hepatology
JF - Nature Reviews Gastroenterology and Hepatology
IS - 5
ER -